Revvity Jan 12, 2026 Revvity, Lilly Expand Access to Federated AI Drug Discovery Models - Lab Manager
Illumina Jan 12, 2026 Illumina names former NIH genomics director as chief medical officer - MedTech Dive
BioPharma Dive Jan 12, 2026 AbbVie buys into PD-1/VEGF sweepstakes; Alnylam and Vertex set expectations
Endpoints News Jan 12, 2026 Eisai licenses Nuvation lung cancer pill; Alnylam's stock dips after sales data report
FierceBiotech Jan 12, 2026 Boston Scientific snaps up Valencia Technologies to bolster urology offerings
FierceBiotech Jan 12, 2026 Lilly, Nvidia tag on partnership with new AI co-innovation lab, $1B investment
FierceBiotech Jan 12, 2026 Bayer boosts imaging portfolio with Attralus deal for 2 diagnostic tracers
Endpoints News Jan 12, 2026 AbbVie jumps into PD-1xVEGF bispecific race, pays $650M upfront to RemeGen